| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT00700622 Details | 2014-10-16 Interventional | 3 | 130 | Insulin Insulin Glargin… Insulin Lispro Insulin, Globin… Diabetes Mellit… Diabetes, Type … | Sponsor stopped development of the MedTone inhaler in favor of an improved device (Gen2
inhaler) - Early termination of trial leading to small numbers of subjects analyzed. | |||
| NCT01653418 Details | 2014-10-15 Interventional | 2 | 10 | Bortezomib Carmustine Cytarabine Etoposide Melphalan Multiple Myelom… Neoplasms, Plas… | Due to the high rate of morbidity and mortality 2 early deaths caused a concern for safety and resulted in suspension of enrollment in May 2013. After a review of the data, the investigators determined that this regimen had unexpected toxicity & the trial was closed to enrollment in June 2013. | |||
| NCT01455246 2010-019625-34 Details | 2014-10-15 Interventional | 2/3 | 32 | Ceftazidime Daptomycin Meropenem Ascites Fibrosis Peritonitis Cirrhosis Nosocomial Spon… | Decision of independent monitoring committee after interim analysis: Risk of failure
significantly higher in ceftazidime group. - | |||
| NCT00766402 Details | 2014-10-15 Interventional | 4 | 8 | Acetaminophen Diclofenac Tramadol Spondylarthriti… Spondylitis Spondylitis, An… Pain | - - | |||
| NCT00742339 Details | 2014-10-15 Interventional | 2/3 | 49 | Midodrine Octreotide Terlipressin Fibrosis Hepatorenal Syn… Liver Cirrhosis Syndrome Cirrhosis | Decision of independent monitoring committee: Risk of non-response to treatment significantly
higher in midodrine group than in terlipressin group. - | |||
| NCT01130909 Details | 2014-10-13 Interventional | 1 | 36 | Ketamine Healthy | The benefit of halting the study to analyze the available data outweighs the benefit of
delaying the analysis to include data from remaining treatment periods - | |||
| NCT01015456 Details | 2014-10-10 Interventional | 3 | 59 | Cyclophosphamid… Mycophenolic Ac… Lupus Nephritis Nephritis | Data Safety Monitoring Board concerning of the participants' safety - | |||
| NCT00571558 Details | 2014-10-09 Interventional | 1 | 15 | Aminolevulinic … Leukoplakia Leukoplakia, Or… Oral Leukoplaki… | - - | |||
| NCT02115594 Details | 2014-10-08 Interventional | 2 | 0 | Entinostat Fulvestrant Breast Neoplasm… Breast Cancer | Internal decision - | |||
| NCT00499590 Details | 2014-10-06 Interventional | 3 | 338 | Ranibizumab Macular Degener… | - Study was terminated early. | |||
| NCT02254525 Details | 2014-10-02 Interventional | 3 | 231 | Ibuprofen Pain, Postopera… Postoperative P… | Sample not reached in traumathology arm - | |||
| NCT01747993 Details | 2014-10-02 Interventional | 3 | 34 | Tamsulosin Urinary Retenti… | low inclusion - | |||
| NCT02254044 Details | 2014-10-01 Interventional | 1 | 7 | Bivatuzumab mer… Maytansine Carcinoma Carcinoma, Squa… Squamous Cell C… | - - | |||
| NCT00982696 NCT00905099 Details | 2014-09-30 Interventional | 2 | 5 | Analgesics, Opi… Enkephalins Mitogens Opioid Peptides Carcinoma, Squa… Head and Neck N… Squamous Cell C… Carcinoma, Squa… | Deemed ineffective - | |||
| NCT01835184 Details | 2014-09-25 Interventional | 1 | 5 | Vemurafenib Melanoma Recurrent Melan… Stage IIIA Mela… Stage IIIB Mela… Stage IIIC Mela… Stage IV Melano… Unspecified Adu… | - - | |||
| NCT00425438 Details | 2014-09-25 Interventional | 3 | 52 | Azathioprine Cyclophosphamid… Mycophenolic Ac… Prednisolone Lupus Nephritis Nephritis | Study was terminated early for administrative reasons. The study was terminated early due to administrative reasons. | |||
| NCT00424294 Details | 2014-09-25 Interventional | 2 | 70 | Celecoxib Methotrexate Arthritis Arthritis, Rheu… | See Detailed Description field The study was terminated early because it was determined that the dual therapy with CP-195543 and celecoxib had poor tolerability and a high discontinuation rate. | |||
| NCT00892242 Details | 2014-09-22 Interventional | 1 | 24 | Zoledronic Acid Pancreatic Neop… Adenocarcinoma | Principal Investigator decided to close the study early. - | |||
| NCT02245438 Details | 2014-09-19 Interventional | 1 | 52 | Estradiol Ethinyl Estradi… Norethindrone Norethindrone A… Norinyl Ritonavir Tipranavir Healthy | - - | |||
| NCT00198159 Details | 2014-09-19 Interventional | 2 | - | Gefitinib Neoplasms, Germ… Refractory Germ… | - - |